• Aucun résultat trouvé

allogeneic stem cell

Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

... Conclusions: The data demonstrate in the largest retrospective cohort of non-cutaneous PTCL so far reported that alloSCT after RIC or MAC is an effective strategy, even in chemoresistant patients. Keywords: ...

12

Allogeneic stem cell transplantation for chronic myelomonocytic leukemia : a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire

Allogeneic stem cell transplantation for chronic myelomonocytic leukemia : a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire

... which allogeneic stem cell transplantation (allo-SCT) remains the only potentially curative ...Conclusions: Allogeneic stem cell transplantation is a valid treatment option for ...

10

Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia

Inferior outcome of allogeneic stem cell transplantation for secondary acute myeloid leukemia in first complete remission as compared to de novo acute myeloid leukemia

... of allogeneic stem cell transplantation (alloSCT), a retrospective, registry-based comparison was performed, including 11,439 patients with de novo and 1325 with ...

10

Peripheral Blood Plasmacytoid Dendritic Cells at Day 100 Can Predict Outcome after Allogeneic Stem Cell Transplantation

Peripheral Blood Plasmacytoid Dendritic Cells at Day 100 Can Predict Outcome after Allogeneic Stem Cell Transplantation

... a b s t r a c t The rapidly increasing use of allogeneic stem cell transplantation (allo-SCT) emphasizes the need for iden- tifying variables predictive of its outcome. Plasmacytoid dendritic cells ...

7

Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

Allogeneic stem cell transplantation for peripheral T cell lymphomas: a retrospective study in 285 patients from the Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

... Conclusions: The data demonstrate in the largest retrospective cohort of non-cutaneous PTCL so far reported that alloSCT after RIC or MAC is an effective strategy, even in chemoresistant patients. Keywords: ...

13

Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases.

Estimating the treatment effect from non-randomized studies: The example of reduced intensity conditioning allogeneic stem cell transplantation in hematological diseases.

... The main objective of this paper was to report exam- ples of treatment estimation from observational cohorts in the particular setting of Allogeneic Stem Cell Trans- plantation. Despite the fact that ...

11

Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature

Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature

... following allogeneic stem cell trans- plantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for ...G. Stem cell transplantation for ...

10

Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: A survey from the acute leukemia working party of EBMT

Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: A survey from the acute leukemia working party of EBMT

... (RIC) allogeneic stem cell transplantation into the mainstay of clinical management of older patients with acute lymphoblastic leukemia (ALL) more than a decade ago [1] represented a significant ...

8

Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial

Results from a clofarabine-busulfan-containing, reduced-toxicity conditioning regimen prior to allogeneic stem cell transplantation: the phase 2 prospective CLORIC trial

... We prospectively evaluated the safety and efficacy of a clofarabine, intravenous busulfan and antithymocyte glob- ulin-based reduced-toxicity conditioning (CloB2A2) regimen before allogeneic stem ...

7

Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies

Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies

... Manuscript received on February 24, 2014. Manuscript accepted on July 24, 2014. Correspondence: blaised@ipc.unicancer.fr The introduction of reduced intensity/toxicity conditioning regimens has allowed allogeneic ...

8

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia

A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia

... The EBMT is a non-profit, scientific society representing more than 600 transplant centers mainly in Europe. The EBMT promotes all activity aiming to improve stem cell transplantation or cellular therapy, ...

9

Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel

Rabbit ATG/ATLG in preventing graft-versus-host disease after allogeneic stem cell transplantation: consensus-based recommendations by an international expert panel

... undergoing allogeneic HSCT indicate that both ATG and ATLG signi ficantly reduce the incidence of GvHD but their administration is associated with delayed immune reconstitution [ 9 , 10 ...hematopoietic stem ...

11

Effet of immune modulation in relapsed peripheral T-cell lymphomas after allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

Effet of immune modulation in relapsed peripheral T-cell lymphomas after allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC)

... TBI Sibling 10/10 Blood 1.6 1 No CT PD 5.5 Abbreviations: aGvH = acute graft versus host disease; ALCL = anaplastic large-cell lymphoma; ALK = anaplastic lymphoma kinase; B = busulfan; CD = conditioning regiment; ...

7

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)

Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation (HSCT)

... Hematopoietic Stem Cell ...given allogeneic hematopoietic cell transplanta- tion after nonmyeloablative ...to Allogeneic Stem Cell Transplantation (allo-SCT) From An HLA ...

7

Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT

Allogeneic hematopoietic stem cell transplantation in solid organ transplant recipients: a retrospective, multicenter study of the EBMT

... first allogeneic stem cell transplantation in all patients (95% confidence intervals were showed as dashed lines) (A) and in recipients of liver (solid line) and kidney (dashed line) grafts ...

10

Acquisition of cancer stem cell capacities after spontaneous cell fusion

Acquisition of cancer stem cell capacities after spontaneous cell fusion

... cancer stem cell marker; it also promotes important characteristics of CS/IC such as drug resistance, cancer cell motility and tumour me- tastasis [ 43 ...hybrid cell line and not on the ...

10

rhEPO in hematopoietic stem cell transplantation

rhEPO in hematopoietic stem cell transplantation

... These trials of rhEPO therapy after allogeneic HSCT have not taken the pathophysiology of erythropoiesis into account. All studies to date have administered very high doses (usually >1,000U/kg/wk) of rhEPO ...

32

Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.

Preemptive cellular immunotherapy after T-cell-depleted allogeneic hematopoietic stem cell transplantation.

... of allogeneic hematopoietic stem cell transplantation (allo-HSCT) ...and cell surface recognition molecules by host cells and thereby enhancing the recognition of host minor or major histo- ...

9

Mesenchymal Stem Cell Features of Ewing Tumors

Mesenchymal Stem Cell Features of Ewing Tumors

... Ewing cell lines (SK- N-MC), despite a strong convergence toward a MSC gene expression profile upon EWS-FLI1 silencing do not differentiate, at least along the adipogenic ...Ewing cell background, although ...

34

Control of the Embryonic Stem Cell State

Control of the Embryonic Stem Cell State

... pluripotent stem cells (iPSCs) have been generated from a broad range of murine and human somatic cells by using forced expression of Oct4, Sox2, and other transcription factors ( Hanna et ...the cell of ...

16

Show all 4130 documents...

Sujets connexes